Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chronic toxicity and long-term outcome in intraoperative electron radiotherapy as boost followed by whole-breast irradiation.
Oses G, Cases C, Valduvieco I, Farrús B, Alonso I, Caparrós X, Mases J, Muñoz-Guglielmetti D, Biete A, Castro C, Escudero E, Molina M, Herreros A, Saez J, Mollà M. Oses G, et al. Among authors: molla m. Clin Transl Oncol. 2021 Aug;23(8):1593-1600. doi: 10.1007/s12094-021-02555-3. Epub 2021 Feb 3. Clin Transl Oncol. 2021. PMID: 33534078
[Evaluation of the efficacy and efficiency of a multidisciplinary unit for the treatment of patients with colorectal cancer].
Soriano A, Castells A, Lacy AM, Ayuso C, Ayuso JR, Conill C, Delgado S, Fuster J, García-Valdecasas JC, Ginès A, Martín M, Maurel J, Miquel R, Mollà M, Vilana R, Castellví-Bel S, Elizalde JI, Piñol V, Pellisé M, Biete A, Gascón P, Piqué JM. Soriano A, et al. Among authors: molla m. Gastroenterol Hepatol. 2002 Dec;25(10):579-84. doi: 10.1016/s0210-5705(02)70319-1. Gastroenterol Hepatol. 2002. PMID: 12459118 Spanish.
Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients.
Cambra MJ, Moreno F, Sanz X, Anglada L, Mollà M, Reyes V, Arenas M, Pedro A, Ballester R, García V, Casals J, Cusidó M, Jimenez C, Escribà JM, Macià M, Solé JM, Arcusa A, Seguí MA, Gonzalez S, Farrús B, Biete A. Cambra MJ, et al. Among authors: molla m. Clin Transl Oncol. 2020 May;22(5):670-680. doi: 10.1007/s12094-019-02168-x. Epub 2019 Jul 1. Clin Transl Oncol. 2020. PMID: 31264148
Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations.
Muñoz-Guglielmetti D, Sanchez-Lorente D, Reyes R, Martinez D, Lucena C, Boada M, Paredes P, Parera-Roig M, Vollmer I, Mases J, Martin-Deleon R, Castillo S, Benegas M, Muñoz S, Mayoral M, Cases C, Mollà M, Casas F. Muñoz-Guglielmetti D, et al. Among authors: molla m. World J Clin Oncol. 2021 Nov 24;12(11):1047-1063. doi: 10.5306/wjco.v12.i11.1047. World J Clin Oncol. 2021. PMID: 34909399 Free PMC article.
395 results